Burden of type 2 diabetes in Asia‐Pacific regions, 1990–2021: GBD 2021 analysis with forecast to 2050
Authors' conclusion
Asia's diabetes burden has continued to increase, driven by population growth, ageing and epidemiological shifts. Targeted prevention, healthcare access and ageing policies are critical, especially in high-burden regions like South and Central Asia.
Study context
- Population
- 35 Asian countries/regions, 1990–202135 Asian countries/regions
Methodological detailsdecomposition analysis, Bayesian Age-Period-Cohort (BAPC) projection
- Decomposition analysis
- Bayesian Age-Period-Cohort (BAPC) projection
Primary result
As reported in the abstract
Fastest-growing age-standardized incidence rate (ASIR): Central Asia, estimated annual percentage change (EAPC)
2.82
Heaviest burden: South Asia, diabetes-related deaths in 2021
410,254
South Asia Disability-adjusted Life-years (DALYs) in 2021
16,851,968
Highest age-standardized mortality rate (ASMR): Southeast Asia
27.84 per 100,000
Further findings
Projected diabetes burden (BAPC model)
- Projections indicate continued increases in diabetes burden in South and Central Asia
Drivers of burden (decomposition analysis)
- Key drivers: population growth, ageing and epidemiological changes, particularly in South Asia
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →